Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00356564
What this trial is testing

Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib

Who this might be right for
Hepatitis B
GlaxoSmithKline 350
Post-approval studies (Phase 4)Study completedNCT01138098
What this trial is testing

Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children

Who this might be right for
Hepatitis B
GlaxoSmithKline 185
Not applicableLooking for participantsNCT06718530
What this trial is testing

Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver Cancer Development

Who this might be right for
Hepatitis C Virus Infection
Centro di Riferimento Oncologico - Aviano 1,000
Large-scale testing (Phase 3)Ended earlyNCT04649515
What this trial is testing

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Who this might be right for
Coronavirus Disease-2019 (COVID-19)
Tychan Pte Ltd. 17
Not applicableStudy completedNCT05689515
What this trial is testing

Feasibility of Positive Links for Youth Care Engagement Intervention

Who this might be right for
HIV Antibody Positivity
The University of Texas Health Science Center at San Antonio 29
Not applicableUnknownNCT04852835
What this trial is testing

Follow-up of COVID-19 Vaccine Response in Strasbourg University Hospitals

Who this might be right for
COVID-19 Vaccines
University Hospital, Strasbourg, France 800
Testing effectiveness (Phase 2)Ended earlyNCT04834908
What this trial is testing

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

Who this might be right for
SARS-CoV-2 Infection
Bharat Serums and Vaccines Limited 7
Testing effectiveness (Phase 2)Study completedNCT03041012
What this trial is testing

Early Administration of Romidepsin and 3BNC117 in Treatment-naïve HIV Patients Starting ART

Who this might be right for
Hiv
Aarhus University Hospital 60
Not applicableActive Not RecruitingNCT04852289
What this trial is testing

A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

Who this might be right for
COVID-19
National Institute on Aging (NIA) 78
Post-approval studies (Phase 4)Study completedNCT02514746
What this trial is testing

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

Who this might be right for
Encephalitis, Japanese
PATH 561
Large-scale testing (Phase 3)Active Not RecruitingNCT06978621
What this trial is testing

Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV

Who this might be right for
Hepatitis AHepatitis A VirusVaccine-Preventable Diseases
Chiang Mai University 36
Testing effectiveness (Phase 2)UnknownNCT04396067
What this trial is testing

Aerosol Combination Therapy of All-trans Retinoic Acid and Isotretinoin as A Novel Treatment for Inducing Neutralizing Antibodies in COVID -19 Infected Patients Better Than Vaccine : An Innovative Treatment

Who this might be right for
COVID-19
Kafrelsheikh University 360
Not applicableStudy completedNCT04816084
What this trial is testing

SERUR: COVID-19 Serological Survey of Staff From the University Reims-Champagne Ardennes

Who this might be right for
Covid19
Université de Reims Champagne-Ardenne 389
Post-approval studies (Phase 4)Study completedNCT01847430
What this trial is testing

Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder

Who this might be right for
Hepatitis B
GlaxoSmithKline 303
Not applicableUnknownNCT04316728
What this trial is testing

Clinical Performance of the VivaDiag ™ COVID-19 lgM / IgG Rapid Test in Early Detecting the Infection of COVID-19

Who this might be right for
Coronavirus Infections
Centro Studi Internazionali, Italy 200
Early research (Phase 1)Study completedNCT04479644
What this trial is testing

Safety, Tolerability, and Pharmacokinetics Study of Human Monoclonal Antibody BRII-198

Who this might be right for
COVID-19
Brii Biosciences Limited 17
Not applicableUnknownNCT04407429
What this trial is testing

Vienna Versus SARS-CoV-2 Virus Study

Who this might be right for
SARS-CoV-2COVID-19
Medical University of Vienna 12,000
Early research (Phase 1)UnknownNCT00300807
What this trial is testing

Study of XTL6865 in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
XTL Biopharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT01843621
What this trial is testing

A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children

Who this might be right for
Dengue
U.S. Army Medical Research and Development Command 7
Not applicableStudy completedNCT04760990
What this trial is testing

Assess the Potential Impact of Disease Modifying Therapies on COVID-19 Outcomes and the Antibody Response Following an Infection With SARS-CoV-2 in Patients With Multiple Sclerosis Within the Swiss Multiple Sclerosis Cohort.

Who this might be right for
Multiple SclerosisCOVID-19 (Severe Coronavirus Disease 2019)
University Hospital, Basel, Switzerland 1,181
Next Page